StopUMTS Logo
how to get rid of moles 
Zoeken
   
Voorlichting
17/05/18Slimme meter: overheidsre
02/05/18Wet kwaliteit, klachten e
Artikelen
25/05/18Deel 1: Straling meten To
24/05/18Cell Phones as Cigarettes
22/05/18Electromagnetic radiation
22/05/18Selected studies on elect
19/05/18Planetary Emergency
15/05/18Pall letter to California
Berichten Nederland
23/05/18WiFi-vrije school Meander
22/05/18Mobiele telefoons veroorz
22/05/18'Met de huidige insectens
17/05/18Slimme meter: Energie bes
17/05/18LTE in april goed voor 39
Berichten België
10/05/18Persbericht: Parlementsle
03/05/18Wallonië ziet af van gro
Berichten Internationaal
21/05/18USA: Kalispell School Boa
18/05/18Geschiedenis van de ontwi
11/05/18Cyprus: Derde video om de
05/05/18COMPILATION of measures t
Ervaringen | Appellen/oproepen
23/05/18Energieverbruik 2 keer zo
29/04/18Huismeting bij een famili
25/04/185 GHz WiFi en hoofdpijn:
Onderzoeken
19/05/18The Effect of the Mret Wa
10/05/18Mathematical Structure fo
10/05/18Exposure of Insects to Ra
Veel gestelde vragen
13/05/17Vakantie? Witte zo
10/07/16Zeven veel gestelde vrage
Juridische informatie
15/05/18Brit dad sues Nokia for u
02/03/18Formal Complaint to the E
26/02/185G From Space & Santa Fe
Oproepen
24/05/18Lezing in Westerhoven: Sm
25/04/18Workshop: EHS en omgaan m
19/04/18Lezing: Smartphones, WiFi
Folders
10/09/17Brochures, folders, websi
29/04/16USA: Meer dan 50 tips voo
Briefwisselingen | Archief: 2008, 2005
23/05/18Mail naar Brandpunt over
04/05/18Ingezonden brief (mail) n
Illustraties
 Algemeen
 Fotoalbum zendmasten
 Wetenschappelijke illustraties
USA/Frankrijk/Brazilië: Zwakke EMV blijken effectief bij de behandeling van o.a. levertumoren.    
Ga naar overzicht berichten in: Onderzoeken

USA/Frankrijk/Brazilië: Zwakke EMV blijken effectief bij de behandeling van o.a. levertumoren.
zondag, 04 december 2011 - Dossier: Algemeen


Zwakke EMV met specifieke frequentiemodulaties blijken effectief bij de behandeling van levertumoren, eierstokkanker en borstkanker bij veldsterkten ver beneden de op warmte-effecten gebaseerde normen. De onderzoekers hebben geen bio-fysische verklaring voor de effecten, het werkingsmechanisme is onbekend:

Bron: British Medical Journal 9 aug. 2011 en 1 dec 2011

Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields

F P Costa1, A C de Oliveira1, R Meirelles1, M C C Machado1, T Zanesco1, R Surjan1, M C Chammas2, M de Souza Rocha2, D Morgan3, A Cantor4, J Zimmerman5, I Brezovich6, N Kuster7, A Barbault8 and B Pasche5

1 Department of Transplantation and Liver Surgery, Hospital das Clínicas da Faculdade de Medicina, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, São Paulo 05403-000, Brazil

2 Department of Radiology, Hospital das Clínicas, University of São Paulo, São Paulo 05403-000, Brazil

3 Department of Radiology, University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL 35294, USA

4 Biostatistics and Bioinformatics Shared Facility, University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL 35294, USA

5 Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham and UAB Comprehensive Cancer Center, 1802 6th Ave South, NP 2566, Birmingham, AL 35294-3300, USA

6 Department of Radiation Oncology, The University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL 35294, USA

7 IT'IS Foundation, Swiss Federal Institute of Technology, Zurich, Switzerland
8Rue de Verdun 20, Colmar 68000, France

Correspondence:
Dr FP Costa, E-mail: fredericoperegocosta@gmail.com;
Dr B Pasche, E-mail: Boris.Pasche@ccc.uab.edu

Therapeutic options for patients with advanced hepatocellular carcinoma (HCC) are limited. There is emerging evidence that the growth of cancer cells may be altered by very low levels of electromagnetic fields modulated at specific frequencies.

Methods:

A single-group, open-label, phase I/II study was performed to assess the safety and effectiveness of the intrabuccal administration of very low levels of electromagnetic fields amplitude modulated at HCC-specific frequencies in 41 patients with advanced HCC and limited therapeutic options. Three-daily 60-min outpatient treatments were administered until disease progression or death. Imaging studies were performed every 8 weeks. The primary efficacy end point was progression-free survival greater than or equal to6 months. Secondary efficacy end points were progression-free survival and overall survival.

Results:

Treatment was well tolerated and there were no NCI grade 2, 3 or 4 toxicities. In all, 14 patients (34.1%) had stable disease for more than 6 months. Median progression-free survival was 4.4 months (95% CI 2.1–5.3) and median overall survival was 6.7 months (95% CI 3.0–10.2). There were three partial and one near complete responses.

Conclusion:

Treatment with intrabuccally administered amplitude-modulated electromagnetic fields is safe, well tolerated, and shows evidence of antitumour effects in patients with advanced HCC.

Voor het originele abstract zie:
www.nature.com/bjc/journal/v105/n5/abs/bjc2011292a.html .

en voor de sceptici zie het follow-up paper van 1 dec 2011:
www.nature.com/bjc/journal/vaop/ncurrent/abs/bjc2011523a.html .

Voor een deskundig Engelstalig commentaar bij deze verbazingwekkende ontdekking zie:
www.microwavenews.com/ModulationFrequencies.html .


Ga terug naar het hoofdmenu
Afdrukken | Vragen | RSS | Disclaimer